Organisation paid for research Program year 2024 Source: CMS Open Payments

Clin Med Research and Development LLC

Neither a doctor nor a teaching hospital

Research payments

$47,214

15 payments

Through program year 2024, Clin Med Research and Development LLC is reported as receiving $47,214 in research payments, across 15 payments.

By program year

3 rows
Year Kind Amount Payments
2024 Research $14,717 6
2023 Research $13,854 5
2022 Research $18,643 4

Breakdown

Who paid Research payments · program years 2022–2024
  1. Biohaven Pharmaceutical Holding Company Ltd. $27,528 7 payments
  2. Pfizer Inc. $19,686 8 payments
Studies the money was for Research payments · program years 2022–2024
  1. A Phase 23 Randomized Doubleblind Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention $28,571 11 payments
  2. A Phase 2/3 Randomized Double-Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention $18,643 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record